What is S23?
S23 or (2S)-N-(4-cyano-3-trifluoromethylphenyl)-3-(3-fluoro-4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide is a new SARM from GTX, Inc. which is developed as a possible male hormonal
contraceptive. It links to the androgen receptor (AR) more intensely (with a Ki of 1.7nM) as compared to older medicines such as Andarine.
In animal research, S23 displayed a good ratio of anabolic to androgenic effects as well as dose-dependent restraint of spermatogenesis (the course of sperm cell development) with unprompted
recuperation after end of treatment.
Chemical Formula: C18H13ClF4N2O3